![](/images/general/no_picture/200_user.png)
Long D Pham
Examiner (ID: 4097, Phone: (571)270-5573 , Office: P/2691 )
Most Active Art Unit | 2691 |
Art Unit(s) | 2691, 2618, 2629 |
Total Applications | 886 |
Issued Applications | 640 |
Pending Applications | 43 |
Abandoned Applications | 203 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14868013
[patent_doc_number] => 20190284248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => PEPTIDES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/427600
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427600 | PEPTIDES, AND USES THEREOF | May 30, 2019 | Abandoned |
Array
(
[id] => 19105809
[patent_doc_number] => 11958890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Antimicrobial proteins
[patent_app_type] => utility
[patent_app_number] => 17/057933
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14939
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057933
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057933 | Antimicrobial proteins | May 28, 2019 | Issued |
Array
(
[id] => 14991115
[patent_doc_number] => 20190314515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/423559
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423559
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423559 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | May 27, 2019 | Pending |
Array
(
[id] => 17036681
[patent_doc_number] => 20210253639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => HETERODIMERIC PEPTIDE REAGENTS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/054900
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054900 | HETERODIMERIC PEPTIDE REAGENTS AND METHODS | May 15, 2019 | Pending |
Array
(
[id] => 16977630
[patent_doc_number] => 20210221867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => Compounds Capable of Binding to Melanocortin 4 Receptor
[patent_app_type] => utility
[patent_app_number] => 17/055347
[patent_app_country] => US
[patent_app_date] => 2019-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055347 | Compounds Capable of Binding to Melanocortin 4 Receptor | May 14, 2019 | Abandoned |
Array
(
[id] => 18664873
[patent_doc_number] => 11771738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Endoparasitic depsipeptides
[patent_app_type] => utility
[patent_app_number] => 17/052571
[patent_app_country] => US
[patent_app_date] => 2019-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30619
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052571 | Endoparasitic depsipeptides | May 6, 2019 | Issued |
Array
(
[id] => 15289219
[patent_doc_number] => 20190387745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN
[patent_app_type] => utility
[patent_app_number] => 16/391272
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/391272 | Biofilm prevention, disruption and treatment with bacteriophage lysin | Apr 21, 2019 | Issued |
Array
(
[id] => 14806357
[patent_doc_number] => 20190269788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/385597
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16385597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/385597 | Antibody-drug-conjugate and its use for the treatment of cancer | Apr 15, 2019 | Issued |
Array
(
[id] => 15254111
[patent_doc_number] => 20190375789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => IMMUNE SYSTEM MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/379654
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 143113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16379654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/379654 | IMMUNE SYSTEM MODULATORS | Apr 8, 2019 | Abandoned |
Array
(
[id] => 14960711
[patent_doc_number] => 20190307833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH NEUROTROPHIC PEPTIDERGIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/373994
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373994 | TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH NEUROTROPHIC PEPTIDERGIC COMPOUND | Apr 2, 2019 | Abandoned |
Array
(
[id] => 14578559
[patent_doc_number] => 20190216888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => USES OF BREMELANOTIDE IN THERAPY FOR FEMALE SEXUAL DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/368417
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368417
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368417 | USES OF BREMELANOTIDE IN THERAPY FOR FEMALE SEXUAL DYSFUNCTION | Mar 27, 2019 | Abandoned |
Array
(
[id] => 17814324
[patent_doc_number] => 11419913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Pharmaceutical compositions for inhibiting inflammatory cytokines
[patent_app_type] => utility
[patent_app_number] => 17/041051
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 14956
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041051 | Pharmaceutical compositions for inhibiting inflammatory cytokines | Mar 27, 2019 | Issued |
Array
(
[id] => 15178133
[patent_doc_number] => 20190359658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => TREATMENT OF DIABETES, TOLL-LIKE RECEPTOR 4 MODULATORS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/356511
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16356511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/356511 | TREATMENT OF DIABETES, TOLL-LIKE RECEPTOR 4 MODULATORS AND METHODS FOR USING THE SAME | Mar 17, 2019 | Abandoned |
Array
(
[id] => 16555769
[patent_doc_number] => 20210000917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => METHODS AND COMPOSITION FOR THE TREATMENT OF ALLERGIC ASTHMA
[patent_app_type] => utility
[patent_app_number] => 16/977883
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977883
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977883 | METHODS AND COMPOSITION FOR THE TREATMENT OF ALLERGIC ASTHMA | Mar 3, 2019 | Pending |
Array
(
[id] => 18233399
[patent_doc_number] => 11597948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Use of ANP32 protein in maintaining the polymerase activity of influenza virus in hosts
[patent_app_type] => utility
[patent_app_number] => 16/755840
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 57
[patent_no_of_words] => 27125
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 325
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755840 | Use of ANP32 protein in maintaining the polymerase activity of influenza virus in hosts | Feb 25, 2019 | Issued |
Array
(
[id] => 14438997
[patent_doc_number] => 20190177371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => NOVEL MODULATORS OF MELANOCORTIN RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/281725
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281725 | NOVEL MODULATORS OF MELANOCORTIN RECEPTORS | Feb 20, 2019 | Abandoned |
Array
(
[id] => 16719991
[patent_doc_number] => 20210087138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => AMINOMETHYL-FUNCTIONALIZED DENATONIUM DERIVATIVES, THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 16/975077
[patent_app_country] => US
[patent_app_date] => 2019-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975077
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975077 | Aminomethyl-functionalized denatonium derivatives, their preparation and use | Feb 19, 2019 | Issued |
Array
(
[id] => 14806387
[patent_doc_number] => 20190269803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => CELL PENETRATING PEPTIDE, CONJUGATE COMPRISING SAME, AND COMPOSITION COMPRISING CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 16/273689
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16273689
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/273689 | Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate | Feb 11, 2019 | Issued |
Array
(
[id] => 14342125
[patent_doc_number] => 20190153035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/265492
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265492 | PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF | Jan 31, 2019 | Abandoned |
Array
(
[id] => 14338909
[patent_doc_number] => 20190151427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the Same
[patent_app_type] => utility
[patent_app_number] => 16/263023
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/263023 | Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the Same | Jan 30, 2019 | Abandoned |